Search | TVST | ARVO Journals

Showing 1 – 20 of 138

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Role of RXR in the Development of Diabetic Retinopathy

Marina S Gorbatyuk; Iuliia Dorofeeva; Assylbek Zhylkibayev; Irina V. Saltykova; Venkatram Atigadda; Bibek Adhikari; Oleg Gorbatyuk; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):853.

ARVO Annual Meeting Abstract June 2024

Ile-Trp dipeptide prevents diabetic retinopathy via gut Indole/AhR/PXR signaling in type 2 diabetes

Ram Prasad; Yvonne Adu-Agyeiwaah; Edgar L Ready V; Sarbodeep Paul; Rati Sharma; Iuliia Dorofeeva; Jason Floyd; Aayush Rohella; Sergio Li Calzi; Bruce Stevens; Qiuhong Li; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):844.

ARVO Annual Meeting Abstract June 2024

Oral alpha-cyclodextrin targets the gut-retinal axis and corrects diabetic retinopathy (DR) in a mouse model of type 2 diabetes (T2D).

Yvonne Adu-Agyeiwaah; Ram Prasad; Sergio Li Calzi; Bright Asare Bediako; Jason Floyd; Mariana D Dupont; Tim Florian Dorweiler; Cristiano Vieira; Irina A Pikuleva; Julia Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):836.

ARVO Annual Meeting Abstract June 2024

Impact of donor and host age on systemic stem cell therapy to treat a mouse model of AMD

Brenton T. Bicknell; Carolina Francelin Rovarotto; Xiaoping Qi; Maria B Grant; Michael Boulton

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):710.

ARVO Annual Meeting Abstract June 2024

The calvarium bone marrow responds to acute retinal injury and is resilient to chronic diabetes compared to long bone marrow.

Sergio Li Calzi; Bright Asare-Bediako; Ram Prasad; Yvonne Adu-Agyeiwaah; Robert F Rosencrans; Jason Floyd; Denise Stanford; Anna Lin; Todd A Lydic; Michael Boulton; Julia Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):325.

ARVO Annual Meeting Abstract June 2024

An engineered probiotic expressing Ang1-7 minimizes the risk of developing diabetic retinopathy in db/db mice

Sarbodeep Paul; Ram Prasad; Yvonne Adu-Agyeiwaah; Edgar L Ready V; Rati Sharma; Iuliia Dorofeeva; Jason Floyd; Aayush Rohella; Sergio Li Calzi; Qiuhong Li; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):323.

ARVO Annual Meeting Abstract June 2024

Intraocular bioerodible implant of carboxyamidotriazole in rabbit models of proliferative retinopathy

Ayaka Fujihashi; Sergio Li Calzi; Yvonne Adu-Agyeiwaah; Bob Katz; Alan Franklin; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):209.

ARVO Annual Meeting Abstract June 2024

Time Restricted Feeding Reduces Retinal Inflammation in Mouse Model of Diet Induced Obesity

Edgar Ready V; Seth Daniel Fortmann; Claudia Edell; Jennifer Pollock; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1682.

ARVO Annual Meeting Abstract June 2024

Impact of gut barrier dysfunction on retinal permeability in diabetic retinopathy

Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1461.

ARVO Annual Meeting Abstract June 2024

FOLR2+ Choroidal Macrophages are a Homeostatic Lipid Handling Subset of Phagocytes that are Depleted in AMD

Seth Daniel Fortmann; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2107.

ARVO Annual Meeting Abstract June 2024

Systemic anti-ceramide immunotherapy corrects diabetic retinopathy by restoring hematopoietic stem cell function

Tim Florian Dorweiler; Arjun Singh; Sandra O'Reilly; Gary Blanchard; Maria B Grant; Richard Kolesnick; Julia V Busik

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3836.

ARVO Annual Meeting Abstract June 2023

LP-ACE2 attenuates diabetic visual impairment by improving gut barrier integrity and intestinal lymphatics in type 1 diabetes

Ram Prasad; Jason Floyd; Yvonne Adu-Agyeiwaah; Bright Asare-Bediako; Sergio Li Calzi; Dibyendu Chakraborty; Angela Harbour; Aayush Rohella; Irina A Pikuleva; Julia V. Busik; Qiuhong Li; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):938.

ARVO Annual Meeting Abstract June 2023

Human iPSC derived CD34 + cells and endothelial colony-forming cells (ECFCs) correct diabetic retinopathy (DR) in a model of type 2 diabetes

Yazen Shihab; Sergio Li Calzi; Yvonne Adu-Agyeiwaah; Cristiano Vieira; Michael E. Boulton; Carolina Francelin Rovarotto; Matt George; Dave Mann; Mervin C. Yoder; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1307.

ARVO Annual Meeting Abstract June 2023

Oral alpha-cyclodextrin reverses cholesterol-crystal-induced retinal pathology in a rodent model of type 2 diabetes (T2D).

Yvonne Adu-Agyeiwaah; Bright Asare-Bediako; Jason Floyd; Mariana D DuPont; Cristiano Vieira; Ram Prasad; Sergio Li Calzi; Irina A Pikuleva; Julia V. Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1834.

ARVO Annual Meeting Abstract June 2023

Fixation Before Dissociation using a Deep Eutectic Solvent Preserves In Vivo Biology in Single-Cells

Seth Fortmann; Blake Frey; Robert Welner; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3924.

ARVO Annual Meeting Abstract June 2023

Characterization of Circulating Immune Cell Subsets in Subjects with DR and DME

Shambhavi Anshumali; Mariana D DuPont; Jason Floyd; Kara Kichler; John Mason; Jason Neal Crosson; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3905.

ARVO Annual Meeting Abstract June 2023

Calvarium bone marrow is the source of bone marrow-derived cells that migrate into the injured retina

Sergio Li Calzi; Bright Asare-Bediako; Yvonne Adu-Agyeiwaah; Ram Prasad; Julia V. Busik; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3866.

ARVO Annual Meeting Abstract June 2023

Ophthalmology Residency Program Director Survey on Pass/Fail USMLE Step 1 Scoring

Ayaka Fujihashi; Ishant Yadav; Kaitlin Burge; Om U. Patel; William Haynes; Ryan Zaniewski; Nicholas Van Wagoner; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5353.

Retina April 2023

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes

PDF

Yvonne Adu-Agyeiwaah; Cristiano P. Vieira; Bright Asare-Bediako; Sergio Li Calzi; Mariana DuPont; Jason Floyd; Sanford Boye; Vince Chiodo; Julia V. Busik; Maria B. Grant
TAGS: diabetes mellitus, diabetes mellitus, type 2, diabetic retinopathy, intravitreal injections, mice, retina, blood capillaries, inflammation, hypoxia
Trans. Vis. Sci. Tech.. 2023; 12(4):20. https://doi.org/10.1167/tvst.12.4.20

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2022

Retinal vessel changes during early-stage diabetic retinopathy

Mariana D DuPont; Kara Kichler; Robert N Mames; Robert Moorthy; Maria B Grant

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):231 – F0078.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Role of RXR in the Development of Diabetic Retinopathy

Ile-Trp dipeptide prevents diabetic retinopathy via gut Indole/AhR/PXR signaling in type 2 diabetes

Oral alpha-cyclodextrin targets the gut-retinal axis and corrects diabetic retinopathy (DR) in a mouse model of type 2 diabetes (T2D).

Impact of donor and host age on systemic stem cell therapy to treat a mouse model of AMD

The calvarium bone marrow responds to acute retinal injury and is resilient to chronic diabetes compared to long bone marrow.

An engineered probiotic expressing Ang1-7 minimizes the risk of developing diabetic retinopathy in db/db mice

Intraocular bioerodible implant of carboxyamidotriazole in rabbit models of proliferative retinopathy

Time Restricted Feeding Reduces Retinal Inflammation in Mouse Model of Diet Induced Obesity

Impact of gut barrier dysfunction on retinal permeability in diabetic retinopathy

FOLR2+ Choroidal Macrophages are a Homeostatic Lipid Handling Subset of Phagocytes that are Depleted in AMD

Systemic anti-ceramide immunotherapy corrects diabetic retinopathy by restoring hematopoietic stem cell function

LP-ACE2 attenuates diabetic visual impairment by improving gut barrier integrity and intestinal lymphatics in type 1 diabetes

Human iPSC derived CD34 + cells and endothelial colony-forming cells (ECFCs) correct diabetic retinopathy (DR) in a model of type 2 diabetes

Oral alpha-cyclodextrin reverses cholesterol-crystal-induced retinal pathology in a rodent model of type 2 diabetes (T2D).

Fixation Before Dissociation using a Deep Eutectic Solvent Preserves In Vivo Biology in Single-Cells

Characterization of Circulating Immune Cell Subsets in Subjects with DR and DME

Calvarium bone marrow is the source of bone marrow-derived cells that migrate into the injured retina

Ophthalmology Residency Program Director Survey on Pass/Fail USMLE Step 1 Scoring

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes

Retinal vessel changes during early-stage diabetic retinopathy

To View More...

You must be signed into an individual account to use this feature.